SCHEMBL7143394

SCHEMBL7143394

CC(C)(C)OC(=O)Nc1cc(Cl)c(-c2ccc(F)cc2)cc1NC(=O)CC(=O)c1cccc(-n2ccnc2)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 6/20 0.40
ABL1 P00519 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
CDK9 P50750 1/20 0.37
GPR142 Q7Z601 1/20 0.36
KDM4D Q6B0I6 1/20 0.35
CYP17A1 P05093 2/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
IDO1 P14902 1/20 0.35
KCNQ4 P56696 1/20 0.34
KCNQ5 Q9NR82 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139934 0.92 ABL1 (0.41) ADH5ABL1L3MBTL1GPR142KDM4D
SCHEMBL7146597 0.92 ADH5 (0.41) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL7147242 0.90 ABL1 (0.41) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL5868843 0.89 CYP17A1 (0.42) ABL1L3MBTL1KDM4DCYP17A1PDE4A
SCHEMBL7139808 0.89 ABL1 (0.39) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL7140968 0.88 ABL1 (0.38) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL7145881 0.88 ABL1 (0.39) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL7145856 0.88 ABL1 (0.38) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL7141902 0.87 ABL1 (0.37) ADH5ABL1L3MBTL1KDM4DCYP17A1
SCHEMBL6434069 0.86 ABL1 (0.44) ADH5ABL1L3MBTL1GPR142KDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed